Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery
- 1 December 2013
- journal article
- Published by Elsevier in Biomaterials
- Vol. 34 (37) , 9638-9647
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumorsBiomaterials, 2013
- Safety and tumor tissue accumulation of pegylated graphene oxide nanosheets for co-delivery of anticancer drug and photosensitizerBiomaterials, 2013
- Hyaluronic acid based scaffolds for tissue engineering—A reviewCarbohydrate Polymers, 2013
- Hyaluronic acid-conjugated graphene oxide/photosensitizer nanohybrids for cancer targeted photodynamic therapyJournal of Materials Chemistry B, 2013
- Intracellular Imaging with a Graphene‐Based Fluorescent ProbeSmall, 2010
- Self-assembled hyaluronic acid nanoparticles for active tumor targetingBiomaterials, 2010
- The chemistry of graphene oxideChemical Society Reviews, 2009
- Signal Transduction of Hyaluronic Acid−Peptide Conjugate for Formyl Peptide Receptor Like 1 ReceptorBioconjugate Chemistry, 2008
- Nano-graphene oxide for cellular imaging and drug deliveryNano Research, 2008
- PEGylated Nanographene Oxide for Delivery of Water-Insoluble Cancer DrugsJournal of the American Chemical Society, 2008